Primary sclerosing cholangitis increases the risk for pancreatitis after endoscopic retrograde cholangiopancreatography

Abstract

The rate of adverse events overall following ERCP in PSC is 18% and PEP occurs in 8%. PSC is an independent risk factor for PEP and the risk is doubled. These findings underline the importance of a careful selection of PSC patients eligible for ERCP as well as a need for high competence of the treating team.